Technology Media and Telecom

U.S. lawmakers call on the government to scrutinize drugmakers' clinical trials in China; China removes restrictions for foreign investments in the manufacturing and services industries; and Cross-Boundary Wealth Connect gains 10 new additional securities firms for increased offshore investment opportunities.

Export pharmaceuticals commissioned for production from a foreign pharmaceutical manufacturer may not be sold and used in the PRC

New rules applicable to Shanghai's Lin-Gang New Area have been released. Wenpei Yu and Yunsi Hu of Lifeng Partners analyze their workings, how they fit into China's existing system of cross-border data transfer rules and why they are so significant for biomedical companies operating in the zone

Nasdaq questioned the identities and backgrounds of Chinese IPO investors; China rolls out new phase of Golden Tax System; and U.S. Congress attempts to prevent Chinese companies from using de minimis loophole to avoid tariffs

U.S. plans to restrict Chinese software in electric and internet-connected cars; China increases control over offshore capital flows; and Chinese firms plan to expand into the U.S. Midwest but have regulatory concerns.

Revised Chinese Company Law requires mandatory worker representation in boardrooms; Shanghai's biomedical measures catch the most attention; and Merchants of Pinduoduo's international arm, Temu, struggle to sue the company due to its complex structure.

WeRide IPO shows another green light for overseas listing of Chinese companies; China imposes new regulations for local authorities to better implement its state secrets law overhaul; and two Chinese state departments release new rules for QFII to stimulate foreign securities investment.

Shenzhen Stock Exchange specifies the reporting requirements for program trading

Casper Sek, partner of Jingtian & Gongcheng, looks at the unique complexities of providing artificial intelligence services in China: one of the most exciting and fast-moving tech markets in the world